Table III.
Open Label | Randomized | ||
---|---|---|---|
Discontinuations, No. (%) | Quinapril 20 mg (n=374) | Quinapril 40 mg (n=167) | Quinapril 20 mg+ Amlodipine Besylate 5 mg (n=162) |
Permanent | |||
All causes | 9 (2.4) | 6 (3.6) | 3 (1.9) |
Study drug‐related AE | 5 (1.3) | 4 (2.4) | 1 (0.6) |
Temporary | |||
All causes | 1 (0.3) | 1 (0.6) | 0 |
Study drug‐related AE | 0 | 0 | 0 |
AE indicates adverse event. |